Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2016-06-27 to 2027-12-31
Current total value of award: $30920844.79
Description: SUPPORT THE INITIATION, MAINTENANCE, AND EXECUTION OF A ZMAPP EAP IN THE US AND AFRICA, INCLUDING CLINICAL, QUALITY, REGULATORY, AND OPERATIONAL SUPPORT AS WELL AS THE EARLY CLINICAL STUDIES (PHASE 1) REQUIRED TO ENABLE FIELD USE OF MBP091 AND MBP134